Crispr has already secured a historic first approval for a CRISPR/Cas9 drug and has several more potential blockbuster ...

In a phase 2 trial, a gene therapy reduced angioedema attacks, which could significantly change the quality of life for ...

University of Wisconsin–Madison researchers targeting a group of hereditary neurodegenerative diseases have found success ...

UW–Madison researchers used gene therapy to prevent hereditary spastic paraplegia (HSP) in a rat model, introducing a healthy ...

Inc. engages in the development of gene editing-based therapies. It provides scientific expertise, clinical development, and intellectual property position to unlock broad therapeutic applications of ...

An RNA-editing gene therapy has been developed that switches off the key driver of common eye conditions affecting diabetics ...

I previously compared the opportunities in CRISPR/Cas9 gene editing to be reminiscent of the golden years of biotech when ...

A new study has made significant strides in plant genome editing by developing an A-to-K base editing system for rice and ...

ZUG, Switzerland and BOSTON, Nov. 07, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CRSP), a biopharmaceutical company focused on ...

Scotland’s leaders are divided on gene editing in agriculture, with new breeding technologies offering potential benefits for the future ...

Intellia Therapeutics reported better-than-expected third-quarter earnings, highlighting advancements in its CRISPR ...